169P - JMJD2A is a novel epigenetic factor of chemotherapeutic susceptibility in gastric cancer
| Autor: | Sato, Y., Nakagawa, T., Tanahashi, T., Kitamura, S., Miyamoto, H., Okamoto, K., Muguruma, N., Takayama, T. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v53-v53 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|